Watch MDCXW. Know when insiders buy.
One email the day a filing lands. Free.
MDCXW
Medicus Pharma Ltd.
No price history available
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
50
WATCH · shorts 50
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$56.7MNET CASH $12.8M52W —SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$11.5M | −$11.6M | — | -0.21 | −$7M | — | — | Aug 12 |
| Q1 2026 · Mar 31 | — | — | — | −$8.6M | −$9M | — | -0.31 | −$9M | — | — | May 14 |
| Q4 2025 · Dec 31derived | — | — | — | −$7.8M | −$15.1M | — | -0.83 | −$6.6M | — | — | Mar 25 |
| Q3 2025 · Sep 30 | — | — | — | −$15 | −$20.9M | — | -1.12 | −$6.8M | — | — | Nov 14 |
| Q2 2025 · Jun 30 | — | — | — | −$6M | −$6.2M | — | -0.43 | −$5.5M | — | — | Aug 12 |
| Q1 2025 · Mar 31 | — | — | — | −$5.1M | −$5.1M | — | -0.42 | −$3.9M | — | — | May 14 |
| Q4 2024 · Dec 31derived | — | — | — | −$3.6M | −$3.5M | — | -0.32 | −$3.2M | — | — | Mar 25 |
| Q3 2024 · Sep 30 | — | — | — | −$2.3M | −$2.3M | — | -0.24 | −$3.1M | — | — | Nov 14 |
| Q2 2024 · Jun 30 | — | — | — | −$3.6M | −$3.6M | — | -0.44 | −$2.8M | — | — | Nov 14 |
| Q1 2024 · Mar 31 | — | — | — | −$1.7M | −$1.7M | — | -0.21 | −$1.2M | — | — | May 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$34.4M | −$47.3M | — | -2.74 | −$22.8M | — | — | — | — |
| FY2024 · to Dec 31 | — | — | −$11.2M | −$11.2M | — | -1.16 | −$10.2M | — | — | — | — |
| FY2023 · to Dec 31 | — | — | −$4.7M | −$5.3M | — | -1.53 | −$4.2M | — | — | — | — |
Every number comes from Medicus Pharma Ltd.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.